AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION.

This document represents the official position of the American Association of Clinical Endocrinologists and the American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

[1]  F. Cosentino,et al.  The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. , 2019, European heart journal.

[2]  P. Novak Electrochemical Skin Conductance Correlates with Skin Nerve Fiber Density , 2016, Front. Aging Neurosci..

[3]  Barry I. Freedman,et al.  Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function. , 2016, Diabetes technology & therapeutics.

[4]  A. Vinik,et al.  Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes , 2016, PloS one.

[5]  B. S. Rasmussen,et al.  Response to Comment on Rasmussen et al. A Randomized Controlled Trial Comparing Telemedical and Standard Outpatient Monitoring of Diabetic Foot Ulcers. Diabetes Care 2015;38:1723–1729 , 2015, Diabetes Care.

[6]  I. Wilkinson,et al.  SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy , 2015, PloS one.

[7]  Donald W. Bowden,et al.  Electrochemical Skin Conductance in Diabetic Kidney Disease , 2015, American Journal of Nephrology.

[8]  M. Roden,et al.  Effect of Low-Energy Diets Differing in Fiber, Red Meat, and Coffee Intake on Cardiac Autonomic Function in Obese Individuals With Type 2 Diabetes , 2015, Diabetes Care.

[9]  A. Vinik,et al.  The New Age of Sudomotor Function Testing: A Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention , 2015, Front. Endocrinol..

[10]  Irl B Hirsch,et al.  American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. , 2015, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[11]  R. D'Agostino,et al.  Autonomic Imbalance as a Predictor of Metabolic Risks, Cardiovascular Disease, Diabetes, and Mortality. , 2015, The Journal of clinical endocrinology and metabolism.

[12]  A. Nicolucci,et al.  Incidence and risk factors for severe and symptomatic hypoglycemia in type 1 diabetes. Results of the HYPOS-1 study , 2015, Acta Diabetologica.

[13]  D. Matthews,et al.  Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2014, Diabetes Care.

[14]  Sandra P. Reyna,et al.  The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy. , 2014, Journal of diabetes and its complications.

[15]  V. Convertino Neurohumoral mechanisms associated with orthostasis: reaffirmation of the significant contribution of the heart rate response , 2014, Front. Physiol..

[16]  Y. Park,et al.  Cardiovascular Autonomic Dysfunction Predicts Severe Hypoglycemia in Patients With Type 2 Diabetes: A 10-Year Follow-up Study , 2013, Diabetes Care.

[17]  A. Vinik,et al.  Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. , 2013, Diabetes technology & therapeutics.

[18]  O. Melander,et al.  Syndromes of orthostatic intolerance: a hidden danger , 2013, Journal of internal medicine.

[19]  A. Vinik,et al.  Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease , 2013, Journal of diabetes investigation.

[20]  R. Freeman,et al.  Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management , 2011, Diabetes/metabolism research and reviews.

[21]  A. Vinik,et al.  Autonomic imbalance: prophet of doom or scope for hope? , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[22]  R. Hermida,et al.  Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes , 2011, Diabetes Care.

[23]  A. Vinik The approach to the management of the patient with neuropathic pain. , 2010, The Journal of clinical endocrinology and metabolism.

[24]  A. Vinik,et al.  Neuropathy: The Crystal Ball for Cardiovascular Disease? , 2010, Diabetes Care.

[25]  M. Bulsara,et al.  Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study. , 2010, The Journal of clinical endocrinology and metabolism.

[26]  J. Dixon,et al.  Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications. , 2010, Pharmacology & therapeutics.

[27]  J. Fleg,et al.  Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial , 2010, Diabetes Care.

[28]  Rodica Pop-Busui,et al.  Cardiac Autonomic Neuropathy in Diabetes , 2010, Diabetes Care.

[29]  J. Albers,et al.  Effects of Prior Intensive Insulin Therapy on Cardiac Autonomic Nervous System Function in Type 1 Diabetes Mellitus: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) , 2009, Circulation.

[30]  P. Nestel,et al.  Weight Loss May Reverse Blunted Sympathetic Neural Responsiveness to Glucose Ingestion in Obese Subjects With Metabolic Syndrome , 2009, Diabetes.

[31]  A. Vinik,et al.  Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.

[32]  Mark E Molitch,et al.  The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. , 2006, Diabetes care.

[33]  M. Lenhard,et al.  Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. , 2005, The Journal of clinical endocrinology and metabolism.

[34]  W. Shoemaker,et al.  Autonomic activity in trauma patients based on variability of heart rate and respiratory rate* , 2004, Critical care medicine.

[35]  Braxton D Mitchell,et al.  The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. , 2003, Diabetes care.

[36]  R. Freeman,et al.  Diabetic autonomic neuropathy. , 2003, Diabetes care.

[37]  A. Burger,et al.  Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy. , 1999, The American journal of cardiology.

[38]  F. Rubino,et al.  The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). , 1999, Journal of diabetes and its complications.

[39]  H Wedel,et al.  Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .

[40]  O. Pedersen,et al.  Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study , 1999, The Lancet.

[41]  F. Gries,et al.  α-Lipoic Acid in the Treatment of Diabetic Peripheral and Cardiac Autonomic Neuropathy , 1997, Diabetes.

[42]  D. Kendall,et al.  Pancreas Transplantation Restores Epinephrine Response and Symptom Recognition During Hypoglycemia in Patients With Long-Standing Type I Diabetes and Autonomic Neuropathy , 1997, Diabetes.

[43]  H Kaufmann,et al.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy , 1996, Clinical Autonomic Research.

[44]  F. A. Gries,et al.  The Epidemiology of Diabetic Neuropathy , 1993 .

[45]  A. Hoes,et al.  2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.

[46]  G. Arsos,et al.  Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy. , 2006, Journal of diabetes and its complications.

[47]  H. Boudoulas,et al.  Long-term effect of converting enzyme inhibition on circadian sympathetic and parasympathetic modulation in patients with diabetic autonomic neuropathy. , 1998, Acta cardiologica.